Liver Fibrosis Treatment Market
The global Liver Fibrosis Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030. The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030. PPARa Agonist Segment to Reach $ Million by 2030, with a % CAGR in next six years. Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-liver-fibrosis-treatment-forecast-2023-2030-72 The global key manufacturers of Liver Fibrosis Treatment include Gilead Sciences, Inc., Merck & Co., Inc., Bristol-Myers Squibb, Johnson and Johnson, Novartis AG, Vertex Pharmaceuticals Incorporated, Pfizer Inc., FibroGen, Inc. and Pharmaxis Limited, etc. In 2022, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveye...